| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MapLight Therapeutics, Inc. | Chief Financial Officer | Voting Common Stock | 395,549 | $7,543,119 | $19.07 | 05 Feb 2026 | Direct |
| MapLight Therapeutics, Inc. | Chief Financial Officer | Employee Stock Option (right to buy) | 31,395 | 05 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MPLT | MapLight Therapeutics, Inc. | 05 Feb 2026 | 2 | $0 | 4 | Chief Financial Officer | 09 Feb 2026, 17:50 |
| MPLT | MapLight Therapeutics, Inc. | 27 Jan 2026 | 1 | -$600,208 | 4 | Chief Financial Officer | 29 Jan 2026, 16:30 |
| MPLT | MapLight Therapeutics, Inc. | 27 Oct 2025 | 2 | $0 | 4 | Chief Financial Officer | 28 Oct 2025, 16:15 |
| MPLT | MapLight Therapeutics, Inc. | 25 Oct 2025 | 0 | $0 | 3 | Chief Financial Officer | 27 Oct 2025, 16:42 |